Cargando…
Application of whole-body FDG-PET for cancer screening in a cohort of hospital employees
Whole-body positron emission tomography/computed tomography with the glucose analog 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG-PET/CT) has been extensively used to screen for underlying malignancies in asymptomatic individuals. We were able to survey a cohort of hospital employees using FDG-PET/CT and t...
Autores principales: | Hu, Chin, Liu, Chun-Peng, Cheng, Jin-Shiung, Chiu, Yu-Li, Chan, Hung-Pin, Peng, Nan-Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591093/ https://www.ncbi.nlm.nih.gov/pubmed/27858845 http://dx.doi.org/10.1097/MD.0000000000005131 |
Ejemplares similares
-
Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017) -
Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population
por: Naganawa, Shotaro, et al.
Publicado: (2017) -
FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study
por: Lawal, Ismaheel O., et al.
Publicado: (2020) -
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer
por: Im, Hyung-Jun, et al.
Publicado: (2016) -
Baseline SUVmax of (18)F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma
por: Xia, Xianwu, et al.
Publicado: (2020)